Company research / CODX

Co-Diagnostics, Inc. (CODX)

CIK 0001692415 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated UT
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Co-Diagnostics, Inc. reported revenue of $622.5K. Revenue fell 84.1% from the prior annual period.

Key ratios (year ended 2025-12-31)

64.3%
Gross margin
-8058.8%
Operating margin
-7533.6%
Net margin
-227.3%
Return on year-end equity
-84.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-09-04

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.